Skip to Content
  • Revenues ($M)
    $22,859
  • Revenue Percent Change
    14.5%
  • Profits ($M)
    $5,144
  • Profits Percent Change
    190%
  • Assets ($M)
    $53,050
  • Employees
    28,000
  • Market Value — as of March 31, 2016 ($M)
    $92,405
  • Previous Rank
    146
  • Morning Consult Brand Index
    D-

The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
Richard A. Gonzalez
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
North Chicago, IL
Websitehttp://www.abbvie.com
Years on Fortune 500 List3
Employees28,000

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$22,85914.5%
Profits ($M)$5,144190%
Assets ($M)$53,050-
Total Stockholder Equity ($M)$3,945-
Market Value — as of March 31, 2016 ($M)$92,405-

Profit Ratios

Profit as % of Revenues22.5%
Profits as % of Assets9.7%
Profits as % of Stockholder Equity130.4%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.13
EPS % Change (from 2014)184.5%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2015)-6.5%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-